Vimarsana
Biggest News Aggregation in the World

Page 8 - Nasdaq Pcvx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Pcvx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pcvx Today - Breaking & Trending Today

Needham & Company LLC Reaffirms Buy Rating for Vaxcyte (NASDAQ:PCVX) - Vimarsana News

Needham & Company LLC Reaffirms Buy Rating for Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a note issued to investors on Wednesday, Benzinga reports. They presently have a $58.00 price target on the stock. Needham & Company LLC’s target price would suggest a potential upside of 22.80% from the […]

Vaxcyte Reports Second Quarter 2023 Financial Results and - Vimarsana News

Vaxcyte Reports Second Quarter 2023 Financial Results and

-- Advanced Ongoing VAX-24 Phase 2 Infant Study to Second Stage, Dosing First New Participants in July 2023; Topline Data from Primary Immunization Series...

Vaxcyte (NASDAQ:PCVX) Shares Gap Down to $47.61 - Vimarsana News

Vaxcyte (NASDAQ:PCVX) Shares Gap Down to $47.61

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $47.61, but opened at $46.29. Vaxcyte shares last traded at $47.31, with a volume of 25,746 shares trading hands. Wall Street Analyst Weigh In A number of research analysts have weighed […]

Source: wkrb13.com
Head to Head Contrast: Titan Pharmaceuticals (NASDAQ:TTNP) vs. Vaxcyte (NASDAQ:PCVX) - Vimarsana News

Head to Head Contrast: Titan Pharmaceuticals (NASDAQ:TTNP) vs. Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Free Report) and Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability. Analyst Ratings This is a summary of recent recommendations for Vaxcyte […]

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Acquired by Vivo Capital LLC - Vimarsana News

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Acquired by Vivo Capital LLC

Vivo Capital LLC grew its position in Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) by 43.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 579,508 shares of the company’s stock after purchasing an additional 175,000 shares during the quarter. Vaxcyte makes up 3.2% of […]